These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21318478)

  • 21. Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.
    Sun J; Tao S; Gao Y; Peng T; Tan A; Zhang H; Yang X; Qin X; Hu Y; Feng J; Kim ST; Lin X; Wu Y; Zhang J; Li Z; Li L; Mo L; Liang Z; Shi D; Huang Z; Huang X; Liu M; Liu Q; Zhang S; Lilly Zheng S; Xu J; Mo Z
    Hum Genet; 2013 Apr; 132(4):423-9. PubMed ID: 23269536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin.
    Pal P; Xi H; Sun G; Kaushal R; Meeks JJ; Thaxton CS; Guha S; Jin CH; Suarez BK; Catalona WJ; Deka R
    Hum Genet; 2007 Nov; 122(3-4):251-9. PubMed ID: 17593395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical activity induced by a germline variation in
    Srinivasan S; Kryza T; Bock N; Tse BW; Sokolowski KA; Panchadsaram J; Moya L; Stephens C; Dong Y; Röhl J; Alinezhad S; Vela I; Perry-Keene JL; Buzacott K; ; Gago-Dominguez M; ; Schleutker J; Maier C; Muir K; Tangen CM; Gronberg H; Pashayan N; Albanes D; Wolk A; Stanford JL; Berndt SI; Mucci LA; Koutros S; Cussenot O; Sorensen KD; Grindedal EM; Key TJ; Haiman CA; Giles GG; Vega A; Wiklund F; Neal DE; Kogevinas M; Stampfer MJ; Nordestgaard BG; Brenner H; Gamulin M; Claessens F; Melander O; Dahlin A; Stattin P; Hallmans G; Häggström C; Johansson R; Thysell E; Rönn AC; Li W; Brown N; Dimeski G; Shepherd B; Dadaev T; Brook MN; Spurdle AB; Stenman UH; Koistinen H; Kote-Jarai Z; Klein RJ; Lilja H; Ecker RC; Eeles R; ; ; Clements J; Batra J
    Res Sq; 2023 Mar; ():. PubMed ID: 37034758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis.
    Zambon CF; Prayer-Galetti T; Basso D; Padoan A; Rossi E; Secco S; Pelloso M; Fogar P; Navaglia F; Moz S; Zattoni F; Plebani M
    J Urol; 2012 Oct; 188(4):1124-30. PubMed ID: 22901566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
    Lin HY; Huang PY; Cheng CH; Tung HY; Fang Z; Berglund AE; Chen A; French-Kwawu J; Harris D; Pow-Sang J; Yamoah K; Cleveland JL; Awasthi S; Rounbehler RJ; Gerke T; Dhillon J; Eeles R; Kote-Jarai Z; Muir K; ; Schleutker J; Pashayan N; ; Neal DE; Nielsen SF; Nordestgaard BG; Gronberg H; Wiklund F; Giles GG; Haiman CA; Travis RC; Stanford JL; Kibel AS; Cybulski C; Khaw KT; Maier C; Thibodeau SN; Teixeira MR; Cannon-Albright L; Brenner H; Kaneva R; Pandha H; ; Srinivasan S; Clements J; Batra J; Park JY
    Sci Rep; 2021 Apr; 11(1):9264. PubMed ID: 33927218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China.
    Chen C; Xin Z
    Medicine (Baltimore); 2017 Mar; 96(10):e6280. PubMed ID: 28272245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function.
    Srinivasan S; Stephens C; Wilson E; Panchadsaram J; DeVoss K; Koistinen H; Stenman UH; Brook MN; Buckle AM; Klein RJ; Lilja H; Clements J; Batra J;
    Clin Chem; 2019 Jan; 65(1):e1-e9. PubMed ID: 30538125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the prostate specific antigen (PSA/KLK3) correlate with male infertility.
    Gupta N; Sudhakar DVS; Gangwar PK; Sankhwar SN; Gupta NJ; Chakraborty B; Thangaraj K; Gupta G; Rajender S
    Sci Rep; 2017 Sep; 7(1):11225. PubMed ID: 28894123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer.
    Hu J; Qiu Z; Zhang L; Cui F
    Diagn Pathol; 2014 Apr; 9():84. PubMed ID: 24755043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Choi WS; Kim D; Kim HJ; Myung SC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):149-56. PubMed ID: 24492489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
    Lou H; Yeager M; Li H; Bosquet JG; Hayes RB; Orr N; Yu K; Hutchinson A; Jacobs KB; Kraft P; Wacholder S; Chatterjee N; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Ma J; Gaziano JM; Stampfer M; Schumacher FR; Giovannucci E; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Anderson SK; Tucker M; Hoover RN; Fraumeni JF; Thomas G; Hunter DJ; Dean M; Chanock SJ
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7933-8. PubMed ID: 19383797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.
    Alvarez-Cubero MJ; Pascual-Geler M; Martinez-Gonzalez LJ; Expósito Ruiz M; Saiz M; Cozar JM; Lorente JA
    Urol Oncol; 2016 Oct; 34(10):431.e1-8. PubMed ID: 27318894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.
    Xu J; Isaacs SD; Sun J; Li G; Wiley KE; Zhu Y; Hsu FC; Wiklund F; Turner AR; Adams TS; Liu W; Trock BJ; Partin AW; Chang B; Walsh PC; Grönberg H; Isaacs W; Zheng S
    Clin Cancer Res; 2008 Sep; 14(18):5819-24. PubMed ID: 18794092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
    Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
    Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
    Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very low PSA concentrations and deletions of the KLK3 gene.
    Rodriguez S; Al-Ghamdi OA; Burrows K; Guthrie PA; Lane JA; Davis M; Marsden G; Alharbi KK; Cox A; Hamdy FC; Neal DE; Donovan JL; Day IN
    Clin Chem; 2013 Jan; 59(1):234-44. PubMed ID: 23169475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
    Helfand BT; Roehl KA; Cooper PR; McGuire BB; Fitzgerald LM; Cancel-Tassin G; Cornu JN; Bauer S; Van Blarigan EL; Chen X; Duggan D; Ostrander EA; Gwo-Shu M; Zhang ZF; Chang SC; Jeong S; Fontham ET; Smith G; Mohler JL; Berndt SI; McDonnell SK; Kittles R; Rybicki BA; Freedman M; Kantoff PW; Pomerantz M; Breyer JP; Smith JR; Rebbeck TR; Mercola D; Isaacs WB; Wiklund F; Cussenot O; Thibodeau SN; Schaid DJ; Cannon-Albright L; Cooney KA; Chanock SJ; Stanford JL; Chan JM; Witte J; Xu J; Bensen JT; Taylor JA; Catalona WJ
    Hum Genet; 2015 Apr; 134(4):439-50. PubMed ID: 25715684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Search for genetic factor association with cancer-free prostate-specific antigen level elevation on the basis of a genome-wide association study in the Korean population.
    Choe EK; Lee Y; Cho JY; Choi SH; Park B; Lee JE; Cho EY
    Eur J Cancer Prev; 2018 Sep; 27(5):453-460. PubMed ID: 28471803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
    Wiklund F; Zheng SL; Sun J; Adami HO; Lilja H; Hsu FC; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang BL; Isaacs WB; Grönberg H; Xu J
    Prostate; 2009 Mar; 69(4):419-27. PubMed ID: 19116992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel prostate cancer susceptibility locus at 19q13.
    Hsu FC; Sun J; Wiklund F; Isaacs SD; Wiley KE; Purcell LD; Gao Z; Stattin P; Zhu Y; Kim ST; Zhang Z; Liu W; Chang BL; Walsh PC; Duggan D; Carpten JD; Isaacs WB; Grönberg H; Xu J; Zheng SL
    Cancer Res; 2009 Apr; 69(7):2720-3. PubMed ID: 19318570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.